FBND | MAMB | FBND / MAMB | |
Gain YTD | 4.706 | 5.635 | 84% |
Net Assets | 20.1B | 133M | 15,113% |
Total Expense Ratio | 0.36 | 1.26 | 29% |
Turnover | 313.00 | 86.00 | 364% |
Yield | 4.59 | 2.21 | 208% |
Fund Existence | 11 years | 4 years | - |
FBND | MAMB | |
---|---|---|
RSI ODDS (%) | 3 days ago38% | N/A |
Stochastic ODDS (%) | 3 days ago47% | 3 days ago63% |
Momentum ODDS (%) | 3 days ago49% | 3 days ago60% |
MACD ODDS (%) | 3 days ago53% | 3 days ago63% |
TrendWeek ODDS (%) | 3 days ago54% | 3 days ago58% |
TrendMonth ODDS (%) | 3 days ago51% | 3 days ago51% |
Advances ODDS (%) | 5 days ago46% | 5 days ago48% |
Declines ODDS (%) | 3 days ago51% | 3 days ago57% |
BollingerBands ODDS (%) | 3 days ago51% | 3 days ago66% |
Aroon ODDS (%) | 3 days ago50% | 3 days ago55% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HQL | 13.86 | 0.21 | +1.54% |
abrdn Life Sciences Investors | |||
GSEE | 52.32 | 0.08 | +0.15% |
Goldman Sachs MarketBeta Emer Mkt Eq ETF | |||
JGRW | 26.87 | 0.03 | +0.09% |
Jensen Quality Growth ETF | |||
XTJA | 30.25 | N/A | N/A |
Innovator US Equity Acclrtd Pls ETF Jan | |||
GRID | 143.46 | -0.42 | -0.29% |
First Trust NASDAQ® Cln Edge®StGidIfsETF |
A.I.dvisor tells us that FBND and NFE have been poorly correlated (+-3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FBND and NFE's prices will move in lockstep.
Ticker / NAME | Correlation To FBND | 1D Price Change % | ||
---|---|---|---|---|
FBND | 100% | -0.15% | ||
NFE - FBND | -3% Poorly correlated | -3.56% |